Landegren N

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis.

Gervais A, Marchal A, Boucherit S, ..., Casanova JL, Jouanguy E

J. Exp. Med. 223 (3) - [2026-03-02; online 2025-12-05]

Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq.

Vazquez SE, Mann SA, Bodansky A, ..., Anderson MS, DeRisi JL

Elife 11 (-) - [2022-10-27; online 2022-10-27]

Author response: Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq

Vazquez SE, Mann SA, Bodansky A, ..., Anderson MS, DeRisi JL

- - (-) - [2022-09-22; online 2022-09-22]

A gene-centric approach to biomarker discovery identifies transglutaminase 1 as an epidermal autoantigen.

Landegren N, Ishii N, Aranda-Guillén M, ..., Hashimoto T, Kämpe O

Proc. Natl. Acad. Sci. U.S.A. 118 (51) - [2021-12-21; online 2021-12-17]

Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'.

Landegren N, Rosen LB, Freyhult E, ..., Anderson M, Kämpe O

Elife 8 (-) - [2019-06-27; online 2019-06-27]

Author response: Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'

Landegren N, Rosen LB, Freyhult E, ..., Anderson M, Kämpe O

- - (-) - [2019-05-31; online 2019-05-31]